Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Recombinant or stably-transformed bacterium encoding one or...
Patent
1981-07-01
1983-12-06
Wiseman, Thomas G.
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Recombinant or stably-transformed bacterium encoding one or...
560 29, 560733, 560136, A61K 3127, C07C125067, C07C125075
Patent
active
044193645
ABSTRACT:
New bronchospasmolytically active compounds exhibiting long duration of action and reduced undesired side effects of the structural formula ##STR1## and therapeutically acceptable salts thereof, in which formula R is selected from the group consisting of --C(CH.sub.3).sub.3, ##STR2## R.sup.1 is selected from the group consisting of H and R.sup.2, R.sup.2 represents the radical of the formula ##STR3## wherein R.sup.3 is selected from the group consisting of (a) H
REFERENCES:
patent: 3937838 (1976-02-01), Wetterlin et al.
patent: 4011258 (1977-03-01), Wetterlin et al.
patent: 4018818 (1977-04-01), Yamamoto et al.
Hornblad et al., Europ J. Clin. Pharmacol., 10, 9-18 (1976).
Zolss, Sci. Pharm., 32, 76-92 (1964).
Minatoya, The Journal of Pharmacology and Experimental Therapeuties, 266, 515-527.
Olsson O. A. Torsten
Svensson Leif A.
Wetterlin Kjell I. L.
Aktiebolaget Draco
Pepper Frederick W.
Wiseman Thomas G.
LandOfFree
Bronchospasmolytic carbamate derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Bronchospasmolytic carbamate derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Bronchospasmolytic carbamate derivatives will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2029677